Neratinib Indications is an orally available tyrosine kinase receptor inhibitor that is used in the extended adjuvant therapy of early-stage breast cancer. Neratinib is associated with a low rate of transient elevations in serum aminotransferase levels during therapy but has not been convincingly linked to Read More …
Neratinib; Uses, Dosage, Side Effects, Interactions
Neratinib is an orally available tyrosine kinase receptor inhibitor that is used in the extended adjuvant therapy of early-stage breast cancer. Neratinib is associated with a low rate of transient elevations in serum aminotransferase levels during therapy but has not been convincingly linked to cases Read More …
Megestrol Contraindications; Pregnancy Category
Megestrol Contraindications is a synthetic derivative of progesterone with an antiestrogenic activity. Megestrol binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of Read More …
Megestrol Indications, Contraindications, Warnings
Megestrol Indications is a synthetic derivative of progesterone with an antiestrogenic activity. Megestrol binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of Read More …
Megestrol; Uses, Dosage, Side Effects, Interactions
Megestrol is a synthetic derivative of progesterone with an antiestrogenic activity. Megestrol binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen Read More …
Megestrol; Uses, Dosage, Side Effects, Interactions
Megestrol is a synthetic derivative of progesterone with an antiestrogenic activity. Megestrol binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen on Read More …
Megestrol Acetate; Uses, Dosage, Side Effects, Interactions
Megestrol Acetate is a synthetic derivative of progesterone with an antiestrogenic activity. Megestrol binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of Read More …
Lapatinib Contraindications, Pregnancy Category
Lapatinib Contraindications is the ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D Read More …
Lapatinib Indications, Contraindications, Warnings
Lapatinib Indications is the ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D Read More …
Lapatinib; Uses, Dosage, Side Effects, Interactions
Lapatinib is the ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell Read More …
Lapatinib Ditosylate; Uses, Dosage, Side Effects, Interactions
Lapatinib Ditosylate is the ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor Read More …
Ribociclib Contraindications, Pregnancy Category
Ribociclib Contraindications/ Ribociclib is an orally available cyclin-dependent kinase (CDK) inhibitor targets at cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. Ribociclib specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb Read More …
